StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Bio Essence

Bio Essence has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bio Essence figures

See a number that looks wrong?